Considering the Inclusion of Metabolic and Cardiovascular Markers in the Panel Study of Income Dynamics

Overview

Journal Biodemography Soc Biol

Publisher Routledge

Specialties Biology
Public Health
Social Sciences

Date 2010 Feb 26

PMID 20183902

Citations 1

Authors

Noreen Goldman

Jennifer B Dowd

Affiliations

Soon will be listed here.

Abstract

The inclusion of biomarkers in social surveys such as the Panel Study of Income Dynamics (PSID) has the potential to answer many elusive questions in social science and public health, including the much-studied relationship between socioeconomic status and health. This article reviews the potential inclusion of biomarkers of cardiovascular and metabolic risk in the PSID. We first discuss the considerable analytical benefits of adding these biomarkers to the PSID, including the exploration of life course hypotheses and the potential to test causal relationships between the social environment and biological systems. Next, we review evidence on the reliability of self-reports of cardiovascular and metabolic risk factors, concluding that the potential bias from relying on self-reports may be substantial. Based on evidence of biological importance as well as practical considerations of ease of in-home collection, our first tier of recommended biomarkers includes measured height, weight, waist and hip circumference, diastolic and systolic blood pressure, resting heart rate, total and high-density lipoprotein (HDL) cholesterol, glycosylated hemoglobin (HbA1c), C-reactive protein (CRP), and cystatin C. Additional markers of secondary priority are also discussed.

Citing Articles

Socioeconomic status and biological markers of health: an examination of adults in the United States and Taiwan.

Cornman J, Glei D, Goldman N, Ryff C, Weinstein M J Aging Health. 2014; 27(1):75-102.

PMID: 24972822 PMC: 4284140. DOI: 10.1177/0898264314538661.

References

Jurdak N, Lichtenstein A, Kanarek R . Diet-induced obesity and spatial cognition in young male rats. Nutr Neurosci. 2008; 11(2):48-54. DOI: 10.1179/147683008X301333. View

Djousse L, Rothman K, Cupples L, Levy D, Ellison R . Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002; 106(23):2919-24. DOI: 10.1161/01.cir.0000042673.07632.76. View

Barker D . Fetal origins of coronary heart disease. BMJ. 1995; 311(6998):171-4. PMC: 2550226. DOI: 10.1136/bmj.311.6998.171. View

Larson S, Dunn A . Behavioral effects of cytokines. Brain Behav Immun. 2002; 15(4):371-87. DOI: 10.1006/brbi.2001.0643. View

Tsuji H, Larson M, Venditti Jr F, Manders E, Evans J, Feldman C . Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996; 94(11):2850-5. DOI: 10.1161/01.cir.94.11.2850. View

Korol D, Gold P . Glucose, memory, and aging. Am J Clin Nutr. 1998; 67(4):764S-771S. DOI: 10.1093/ajcn/67.4.764S. View

Barker D, Eriksson J, Forsen T, Osmond C . Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2003; 31(6):1235-9. DOI: 10.1093/ije/31.6.1235. View

Greenberg J, Fontaine K, Allison D . Putative biases in estimating mortality attributable to obesity in the US population. Int J Obes (Lond). 2007; 31(9):1449-55. DOI: 10.1038/sj.ijo.0803615. View

Melzer D, Lan T, Tom B, Deeg D, Guralnik J . Variation in thresholds for reporting mobility disability between national population subgroups and studies. J Gerontol A Biol Sci Med Sci. 2005; 59(12):1295-303. DOI: 10.1093/gerona/59.12.1295. View

10.

Papanicolaou D, Wilder R, Manolagas S, Chrousos G . The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998; 128(2):127-37. DOI: 10.7326/0003-4819-128-2-199801150-00009. View

11.

Nauck M, Warnick G, Rifai N . Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002; 48(2):236-54. View

12.

Rifai N . High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome. Clin Chem. 2005; 51(3):504-5. DOI: 10.1373/clinchem.2004.044990. View

13.

Heckman J . Skill formation and the economics of investing in disadvantaged children. Science. 2006; 312(5782):1900-2. DOI: 10.1126/science.1128898. View

14.

Benyamini Y, Blumstein T, Lusky A, Modan B . Gender differences in the self-rated health-mortality association: is it poor self-rated health that predicts mortality or excellent self-rated health that predicts survival?. Gerontologist. 2003; 43(3):396-405; discussion 372-5. DOI: 10.1093/geront/43.3.396. View

15.

Stamler J . Low risk--and the "No more than 50%" myth/dogma. Arch Intern Med. 2007; 167(6):537-9. DOI: 10.1001/archinte.167.6.537. View

16.

Wilson A, Ryan M, Boyle A . The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2005; 106(3):291-7. DOI: 10.1016/j.ijcard.2005.01.068. View

17.

Amick 3rd B, McDonough P, Chang H, Rogers W, Pieper C, Duncan G . Relationship between all-cause mortality and cumulative working life course psychosocial and physical exposures in the United States labor market from 1968 to 1992. Psychosom Med. 2002; 64(3):370-81. DOI: 10.1097/00006842-200205000-00002. View

18.

Ben-Shlomo Y, Kuh D . A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002; 31(2):285-93. View

19.

Thomas M, Walker M, Emberson J, Thomson A, Lawlor D, Ebrahim S . Prevalence of undiagnosed Type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med. 2005; 22(6):789-93. DOI: 10.1111/j.1464-5491.2005.01516.x. View

20.

Lloyd-Jones D, Liu K, Tian L, Greenland P . Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med. 2006; 145(1):35-42. DOI: 10.7326/0003-4819-145-1-200607040-00129. View